CLOV vs VERO · rev $1.37B vs rev $64.8M
Clover Health Investments Corp (CLOV) versus Venus Concept Inc (VERO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
CLOV currently screens at market cap $1.55B. VERO currently screens at market cap $578.2K.
Not investment advice. Open the CLOV and VERO stock pages for the full models.
Not investment advice.